Novo Nordisk A/S stock price
NVO
#63

₺1.864,47
  

6.87%

Novo Nordisk A/S Info

Piyasa değ.
₺8,26T

6.87%

Günlük Hacim
₺43,32B
Varlık türü
Hisse S.
Çalışanlar
78387
Kuruluş
Dec 21, 1923
Temel borsa
New York Stock Exchange
CIK numarası
0000353278

Tokenize Hisse Verileri

Ort. Tokenize Fiyat
₺1,89K
Fiyat Farkı
+₺27,02(+1.45%)
Tokenize Piy. Değ.
₺154,92M

0.06%

Tokenize Hac. (24s)
₺36,98M

9.82%

İhraççı
Sözleşmeler
Gezginler
NVO/USD Dönüştürücü
NVO
TRY
Fiyat performansı
Düşük
₺1,72K
Yüksek
₺1,86K

Veriler Yükleniyor

Grafik verilerini yüklüyoruz, lütfen bekleyin

Novo Nordisk A/S topluluğu

skeleton-white
 
 
 
 
 
 

About Novo Nordisk A/S

What is Novo Nordisk A/S?

With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Novo Nordisk A/S Fiyatı Canlı Veri

The current price of Novo Nordisk A/S in the market is ₺1.864,47, with a 24-hour trading volume of ₺43,32B. The asset's market cap is ₺8,26T, after moving 6.88% in the last day.

Tokenized Novo Nordisk A/S is trading at ₺1.891,49, with a tokenized market cap of ₺154,92M and a 24-hour trading volume of ₺36,98M. The tokenized asset has moved -0.06% in the past 24 hours.